The World Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study

• Andrea I. Zambrano,

  Affiliation Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland

  ⨯
• Shekhar Sharma,

  Affiliation National Trachoma Program, Nepal Netra Jyoti Sangh (NNJS), Kathmandu, Nepal

  ⨯
• Kathryn Crowley,

  Affiliation RTI International, Washington, DC, United States of America

  ⨯
• Laura Dize,

  Affiliation International Chlamydia Laboratory, Johns Hopkins Hospital, Baltimore, Maryland, United States of America

  ⨯
• Beatriz E. Muñoz,

  Affiliation Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland

  ⨯
• Sailesh K. Mishra,

  Affiliation National Trachoma Program, Nepal Netra Jyoti Sangh (NNJS), Kathmandu, Nepal

  ⨯
• Lisa A. Rotondo,

  Affiliation RTI International, Washington, DC, United States of America

  ⨯
• Charlotte A. Gaydos,

  Affiliation International Chlamydia Laboratory, Johns Hopkins Hospital, Baltimore, Maryland, United States of America

  ⨯
• Sheila K. West

  * E-mail: shwest@jhmi.edu

  Affiliation Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland

  ⨯